Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FERDINAND MEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.5% 0.9% 1.1% 1.3% 1.0% 1.4% 8.9% 8.9%   Credit score (0-100)   78 90 84 78 86 76 28 28   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   12.9 260.1 144.4 47.2 269.2 34.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,339 2,857 3,886 4,452 4,516 4,936 0.0 0.0   EBITDA   199 559 787 732 908 547 0.0 0.0   EBIT   199 559 787 732 908 547 0.0 0.0   Pre-tax profit (PTP)   201.4 557.6 782.3 721.7 901.6 550.3 0.0 0.0   Net earnings   152.3 428.2 603.6 551.3 676.8 414.7 0.0 0.0   Pre-tax profit without non-rec. items   201 558 782 722 902 550 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   2,164 2,592 2,696 3,047 3,724 4,139 3,714 3,714   Interest-bearing liabilities   0.0 27.4 29.4 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,073 4,244 4,825 7,189 6,713 7,675 3,714 3,714   Net Debt   -751 -442 -38.7 -176 -138 -1,681 -3,714 -3,714     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,339 2,857 3,886 4,452 4,516 4,936 0.0 0.0   Gross profit growth   -11.5% 22.2% 36.0% 14.6% 1.5% 9.3% -100.0% 0.0%   Employees   0 4 4 4 5 5 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 25.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,073 4,244 4,825 7,189 6,713 7,675 3,714 3,714   Balance sheet change%   -3.8% 4.2% 13.7% 49.0% -6.6% 14.3% -51.6% 0.0%   Added value   199.4 558.9 787.4 731.9 908.2 547.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.5% 19.6% 20.3% 16.4% 20.1% 11.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.8% 13.5% 17.4% 12.2% 13.1% 7.7% 0.0% 0.0%   ROI %   8.6% 23.4% 29.5% 25.4% 26.8% 14.1% 0.0% 0.0%   ROE %   6.5% 18.0% 22.8% 19.2% 20.0% 10.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   53.1% 61.1% 55.9% 42.4% 55.5% 53.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -376.6% -79.0% -4.9% -24.0% -15.2% -307.1% 0.0% 0.0%   Gearing %   0.0% 1.1% 1.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 15.5% 21.6% 70.8% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.9 0.6 0.5 0.6 0.7 1.1 0.0 0.0   Current Ratio   2.1 2.6 2.3 1.7 2.2 2.2 0.0 0.0   Cash and cash equivalent   750.9 469.1 68.0 175.8 138.1 1,680.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,103.9 2,594.1 2,710.6 2,987.1 3,663.9 4,078.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 140 197 183 182 109 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 140 197 183 182 109 0 0   EBIT / employee   0 140 197 183 182 109 0 0   Net earnings / employee   0 107 151 138 135 83 0 0